Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  idoxuridine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 30 for your search:
Start Over
Phase III Randomized Trial of Radiotherapy plus IUDR as a Radiosensitizer vs Radiotherapy Alone in Patients with Unresectable Sarcoma (Summary Last Modified 04/92)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 80
Sponsor: NCI
Protocol IDs: NCI-88-C-02, NCI-T88-0022N, T88-0022
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066413, RUSH-AML-9754, ALZA-RUSH-AML-9754, NCI-V98-1445, NCT00003405
Phase II Study of Radiosensitization with IUdR Concurrent with Radiotherapy in Patients with Unfavorable Neoplasms
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 to 80
Sponsor: NCI
Protocol IDs: NCI-88-C-0003B, NCI-T88-0020N, T88-0020
Phase II Evaluation of IUdR Infusion and Radiotherapy in the Treatment of Head and Neck, Truncal, Retroperitoneal, and Extremity Soft Tissue Sarcomas (Summary Last Modified 01/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CCUM-8802, NCI-T88-0121O, T88-0121
Phase II Study of LIF (CF/IUDR/5-FU) in Patients with Advanced Colorectal Cancer (Summary Last Modified 05/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GUMC-19692, NCI-T92-0070D, T92-0070
Phase II Study of LIF (CF/IUDR/5-FU) in Patients with Advanced Pancreatic Cancer (Summary Last Modified 10/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GUMC-19992, NCI-T92-0060D, T92-0060
Phase I Pilot Study of Intra-Arterial 125I/131I-IUDR in Hepatic Metastases from Colorectal Cancer (Summary Last Modified 11/94)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-94014, NCI-V94-0461
Phase I Study of Accelerated Hyperfractionated Radiotherapy and IUDR for High-Grade Gliomas (Summary Last Modified 01/2000)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9392, NCI-T93-0059C, T93-0059
Phase I Randomized Study of Intravenous IUDR in Advanced Malignancies (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CHNMC-IRB-94146, NCI-T94-0201D, T94-0201
Phase I Study of Raltitrexed (Tomudex) and Idoxuridine (IUDR) in Advanced Adult Solid Tumors (Summary Last Modified 04/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-960104, NCI-T96-0083, T96-0083
Phase I Evaluation of Iododeoxyuridine (NSC-39661) Administered as a Constant Intravenous Infusion
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-83-C-135, NCI-ROB-831, NCI-T83-1021W, T83-1021
Phase I Pilot Chemotherapy with Intra-arterial 5-FU/IUDR for Hepatic Metastases from Colorectal Carcinoma
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-8321, NCI-T84-0191D, T84-0191
Phase I Study of Iododeoxyuridine Given as a Constant Intrahepatic Arterial Infusion Prior to Radiotherapy in Patients with Unresectable Liver Metastases
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-86-C-222B, NCI-T87-0020N, T87-0020
Phase I Study of IUdR plus Radiotherapy in Patients with Primary Malignant Brain Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: RTOG-8612, RTOG-86-12
Phase I Study of IUdR/BLEO in Patients with Advanced Solid Tumors (Summary Last Modified 03/88)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-5480, NCI-T87-0293O, T87-0293
Phase I Trial of BLEO/IUdR in Patients with Advanced Malignancies (Summary Last Modified 11/92)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: AUS-T88-0120, NCI-T88-0120A, T88-0120
Phase I Study of IUDR Combined with 5-FU/CF in Patients with Advanced Colorectal and Other Cancers (Summary Last Modified 03/92)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GUMC-13090, NCI-T90-0113O, T90-0113
Phase I Study of Intraperitoneal IUDR with or without Intravenous High-Dose CF in Patients with Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CHNMC-IRB-90131, NCI-T90-0183D, T90-0183
A Phase I Study of IUDR/CF as Radiosensitizers in Advanced Gastrointestinal Cancer (Summary Last Modified 06/94)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9096, NCI-T90-0237C, T90-0237
Phase I Study of IUDR/PALA/5-FU/CF in Patients with Advanced Cancer (Summary Last Modified 03/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GUMC-91140, NCI-T91-0014D, T91-0014
Start Over